Sekeres MA - Search Results

1

Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes.

Padron E, Ball MC, Teer JK, Painter JS, Yoder SJ, Zhang C, Zhang L, Moscinski LC, Rollison DE, Gore SD, Bejar R, Walter MJ, Sekeres MA, Komrokji RS, Epling-Burnette PK. Padron E, et al. Among authors: sekeres ma. Blood. 2018 May 24;131(21):2402-2405. doi: 10.1182/blood-2018-01-827881. Epub 2018 Apr 16. Blood. 2018. PMID: 29661788 Free PMC article. No abstract available.

2

The myelodysplastic syndromes.

Sekeres MA. Sekeres MA. Expert Opin Biol Ther. 2007 Mar;7(3):369-77. doi: 10.1517/14712598.7.3.369. Expert Opin Biol Ther. 2007. PMID: 17309328 Review.

3

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.

Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski JP. Gondek LP, et al. Among authors: sekeres ma. Blood. 2008 Feb 1;111(3):1534-42. doi: 10.1182/blood-2007-05-092304. Epub 2007 Oct 22. Blood. 2008. PMID: 17954704 Free PMC article.

4

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.

Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C, Sekeres M, Saunthararajah Y, Maciejewski JP. Jiang Y, et al. Blood. 2009 Feb 5;113(6):1315-25. doi: 10.1182/blood-2008-06-163246. Epub 2008 Oct 2. Blood. 2009. PMID: 18832655 Free PMC article.

5

REVelation (del: 5q).

Sekeres MA. Sekeres MA. Blood. 2009 Apr 23;113(17):3888-9. doi: 10.1182/blood-2008-12-191478. Blood. 2009. PMID: 19389890 Free article. No abstract available.

6

Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease: implications for clinical trial design and enrollment.

Sekeres MA, Steensma DP. Sekeres MA, et al. Blood. 2009 Sep 24;114(13):2575-80. doi: 10.1182/blood-2009-06-228114. Epub 2009 Jul 15. Blood. 2009. PMID: 19605847 Free PMC article. Review.

7

If Nostradamus were treated for MDS.

Sekeres MA. Sekeres MA. Blood. 2011 Jan 13;117(2):374-5. doi: 10.1182/blood-2010-10-314401. Blood. 2011. PMID: 21233319 Free article. No abstract available.

8

Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.

Tiu RV, Gondek LP, O'Keefe CL, Elson P, Huh J, Mohamedali A, Kulasekararaj A, Advani AS, Paquette R, List AF, Sekeres MA, McDevitt MA, Mufti GJ, Maciejewski JP. Tiu RV, et al. Among authors: sekeres ma. Blood. 2011 Apr 28;117(17):4552-60. doi: 10.1182/blood-2010-07-295857. Epub 2011 Feb 1. Blood. 2011. PMID: 21285439 Free PMC article.

9

Management of lower-risk myelodysplastic syndromes: the art and evidence.

Komrokji RS, Sekeres MA, List AF. Komrokji RS, et al. Among authors: sekeres ma. Curr Hematol Malig Rep. 2011 Jun;6(2):145-53. doi: 10.1007/s11899-011-0086-x. Curr Hematol Malig Rep. 2011. PMID: 21442178 Review.

10

SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.

Afable MG 2nd, Wlodarski M, Makishima H, Shaik M, Sekeres MA, Tiu RV, Kalaycio M, O'Keefe CL, Maciejewski JP. Afable MG 2nd, et al. Among authors: sekeres ma. Blood. 2011 Jun 23;117(25):6876-84. doi: 10.1182/blood-2010-11-314393. Epub 2011 Apr 28. Blood. 2011. PMID: 21527527 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

424 results

Search Page